Malley, Kaitlyn M.
Ruiz, Andrea D.
Darrow, Michael J.
Danaphongse, Tanya
Shiers, Stephanie
Ahmad, Fatima N.
Mota-Beltran, Clareth
Stanislav, Benjamin T.
Price, Theodore J.
Rennaker, Robert L. II
Kilgard, Michael P.
Hays, Seth A. https://orcid.org/0000-0003-4225-241X
Funding for this research was provided by:
National Institutes of Health (NIH R01 NS094384)
U.S. Department of Defense (W81XWH-20-1-0863)
Article History
Received: 17 January 2024
Accepted: 13 August 2024
First Online: 21 August 2024
Competing interests
: MPK has a financial interest in MicroTransponder, Inc. RLR is the co-founder and CEO of XNerve, which is developing nerve stimulation therapies. The other authors declare that no competing interests exist.